Carbon Silicon Ventures
Backing founders transforming Biology into an engineering discipline.
- Ansa Biotechnologies (press)
Enzymatic DNA synthesis platform that eliminates the length and complexity ceiling of phosphoramidite chemistry.
- Octant (press)
Engineering multi-target corrector molecules through massively multiplexed, RNA-barcoded human cell assays.
- Basepair
Automated bioinformatics and genomic data management infrastructure that runs natively within customer cloud environments.
- Medra AI
Building a Physical AI Scientist to collect biological data at scale.
- Femtofluidics
Ultra-high-throughput digital microfluidic platforms for high-throughput assays and chemical synthesis.
- Sphinx Bio (Acquired)
Data infrastructure and computational platform for complex biological datasets.
- Olden Labs
Automated animal research infrastructure for continuous health monitoring and high-fidelity experimental data capture.
- Bluenote Health (press)
AI-driven automation that accelerates regulatory submissions and clinical development workflows for life science companies.
- Tetsuwan Scientific (press)
Science-native AI to make automation usable for protocol development in life science laboratories.
- Current Surgical
Smart surgical needle for ultra-precise tumor ablation guided by high-resolution ultrasound imaging.
- Oligonucleotide Company (TBA)
- Drug Delivery Company (TBA)
- Cloud Lab Company (TBA)
- Protein Design Company (TBA)
- RNA Therapeutics Company (TBA)
Email:
hello@carbonsilicon.vc